ClinicalTrials.gg
Status unknownNCT03873077Updated Mar 13, 2019

Effect of LIA on Postoperative Pain Following ACL Reconstruction

An interventional study of local infiltration analgesia in Anterior Cruciate Ligament Rupture and Pain, Postoperative, sponsored by Algemeen Ziekenhuis Maria Middelares. Status unknown at 1 site in Belgium. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2019-03-13.

Sponsored by Algemeen Ziekenhuis Maria Middelares · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Mar 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

An anterior cruciate ligament (ACL) rupture is one of the most common sport injuries, which typically develops after a sudden knee torsion. Arthroscopic repair of the ACL is often required as a complete ACL tear can cause instability of the knee joint.

During arthroscopic reconstruction the lower leg is reattached to the upper leg using part of the hamstring tendon (mm. gracilis and mm. semitendinosus). Optimal postoperative analgesia is necessary to allow a quick recovery. Intravenous analgesia during surgery is often associated with a number of side effects such as nausea, vomiting and muscle weakness and does not anesthetize the donor site of the hamstring tendon graft. Local infiltration of ropivacaine and lidocaine in the knee joint and at the donor site can be a valuable asset to control the postoperative pain.

This study evaluates the effect of local infiltration analgesia (LIA) on the postoperative pain in the first month after an ACL reconstruction. Half of participants will only receive intravenous analgesia during surgery, the other half will receive intravenous analgesia and a LIA.

Read the detailed description

2 x 20 patients which are planned for arthroscopic ACL reconstruction are randomised: standard-group and LIA-group.

All patients receive standardised multimodal intravenous analgesia. After standardised induction of anesthesia, patient positioning and administration of basic analgetics (paracetamol, diclofenac, clonidine and morfine), patients in the LIA-group receive a local infiltration in the knee of 10 mL ropivacaine and 10 mL lidocaine.

Visual Analogue Scores are assessed 15 minutes after awakening from surgery and on Day 1, 2, 3, 7, 14, 21 and 28 after surgery. Postoperative analgesic consumption are registered in the first month after the surgery. The quality of recovery after anesthesia is assessed on Day 1 by the postoperative quality of recovery score (QoR-15).

02

Conditions studied

  • Anterior Cruciate Ligament Rupture
  • Pain, Postoperative

Keywords

  • local infiltration analgesia
  • postoperative analgesia
03

In context

Anterior Cruciate Ligament Injuries

521 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 169 are open to participants now.

This study's planned enrollment of 40 is below the median of 56 across 378 interventional studies indexed under Anterior Cruciate Ligament Injuries.

Browse Anterior Cruciate Ligament Injuries studies →

Lead sponsor

Algemeen Ziekenhuis Maria Middelares is the lead sponsor of 37 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • elective arthroscopic anterior cruciate ligament reconstruction
  • adult

Exclusion criteria

Exclusion Criteria:

  • unwilling or unable to grant written informed consent
  • revisions
  • contra-indication for ropivacaine
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • No intervention
    intravenous analgesia

    Patient receives intravenous analgesia: paracetamol 30 mg/kg, diclofenac 75 mg, clonidine 1 µg/kg and morfine 0,05 mg/kg

  • Other
    intravenous analgesia + LIA

    Patient receives intravenous analgesia and a local infiltration analgesia in the knee

    Procedure: local infiltration analgesia

Interventions

  • Procedurelocal infiltration analgesia

    10 mL ropivacaine 7.5 mg/mL and 10 mL lidocaine 10 mg/mL

06

What researchers measure

Primary outcomes

  1. Visual Analogue Scale for pain

    Pain intensity using the VAS (where 0 = no pain and 100 = pain as bad as can be) 15 minutes after awakening and on Day 1, 2, 3, 7, 14, 21 and 28 after surgery.

    Time frame: From moment of surgery until one month after surgery

Secondary outcomes

  1. Postoperative analgesia consumption

    Dosing and frequency of analgesia consumption

    Time frame: From moment of surgery until one month after surgery

  2. General patient comfort

    Quality of recovery score (QoR-15) on the first day after surgery

    Time frame: From moment of surgery until one day after surgery

  3. Incidence of nausea and vomiting

    Incidence of postoperative nausea and vomiting

    Time frame: From moment of surgery until hospital discharge (one day after surgery)

  4. PONV treatment

    Number of pharmacological treatments for postoperative nausea and vomiting (PONV)

    Time frame: From moment of surgery until hospital discharge (one day after surgery)

07

Study locations

1 of 1 sites recruiting
  • General Hospital Maria Middelares
    Ghent, Oost-Vlaanderen 9000, Belgium
    • Alain F Kalmar · Contact
    Recruiting
08

References and documents

Publications

  • Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology. 2013 Jun;118(6):1332-40. doi: 10.1097/ALN.0b013e318289b84b. PubMed 23411725 ↗
  • Lefevre N, Klouche S, de Pamphilis O, Herman S, Gerometta A, Bohu Y. Peri-articular local infiltration analgesia versus femoral nerve block for postoperative pain control following anterior cruciate ligament reconstruction: Prospective, comparative, non-inferiority study. Orthop Traumatol Surg Res. 2016 Nov;102(7):873-877. doi: 10.1016/j.otsr.2016.07.011. Epub 2016 Oct 4. PubMed 27720193 ↗
  • Kerr DR, Kohan L. Local infiltration analgesia: a technique for the control of acute postoperative pain following knee and hip surgery: a case study of 325 patients. Acta Orthop. 2008 Apr;79(2):174-83. doi: 10.1080/17453670710014950. PubMed 18484242 ↗
  • Kristensen PK, Pfeiffer-Jensen M, Storm JO, Thillemann TM. Local infiltration analgesia is comparable to femoral nerve block after anterior cruciate ligament reconstruction with hamstring tendon graft: a randomised controlled trial. Knee Surg Sports Traumatol Arthrosc. 2014 Feb;22(2):317-23. doi: 10.1007/s00167-013-2399-x. Epub 2013 Jan 23. PubMed 23338666 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 13, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03873077
Lead sponsor
Algemeen Ziekenhuis Maria Middelares
Responsible party
Dr. Alain Kalmar, MD, PhD (Staff Anesthesist, Algemeen Ziekenhuis Maria Middelares) — Principal investigator
First posted
Mar 13, 2019
Start date
Mar 1, 2019
Primary completion
Feb 2020 (estimated)
Completion
Mar 2020 (estimated)
Last update
Mar 13, 2019

Study contacts

Alain F Kalmar, MD, PhD, MSc
Contact
alainkalmar@gmail.com
+32 246 17 29
Pieter Byn, MD, Msc
Contact
pieterbyn@hotmail.com
Alain F Kalmar
principal investigator · Maria Middelares Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion